These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 5573579

  • 21. [Should typhoid-paratyphoid vaccination be continued?].
    Mercier P, Antoine HM.
    Bull Acad Natl Med; 1979 May; 163(5):446-50; discussion 450-1. PubMed ID: 15648337
    [No Abstract] [Full Text] [Related]

  • 22. Haematuria caused by oral typhoid vaccine.
    Shenoy JB, Guido S.
    J Assoc Physicians India; 1999 Aug; 47(8):845-6. PubMed ID: 10778645
    [No Abstract] [Full Text] [Related]

  • 23. Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine.
    Dumas R, Forrat R, Lang J, Farinelli T, Loutan L.
    Adv Ther; 1997 Aug; 14(4):160-7. PubMed ID: 10174195
    [Abstract] [Full Text] [Related]

  • 24. Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002.
    Begier EM, Burwen DR, Haber P, Ball R, Vaccine Adverse Event Reporting System Working Group.
    Clin Infect Dis; 2004 Mar 15; 38(6):771-9. PubMed ID: 14999618
    [Abstract] [Full Text] [Related]

  • 25. Intradermal versus subcutaneous typhoid vaccination.
    Dimache G, Dimache V, Pavel A, Croitoru M.
    Arch Roum Pathol Exp Microbiol; 1981 Mar 15; 40(2):143-8. PubMed ID: 7305649
    [No Abstract] [Full Text] [Related]

  • 26. [Incidence and variations of proteinuria following TABT vaccination].
    Tomasević M, Petrović B, Kamenković J, Purisić S.
    Vojnosanit Pregl; 1972 Jan 15; 29(1):11-3. PubMed ID: 5011130
    [No Abstract] [Full Text] [Related]

  • 27. Transverse myelitis following cholera, typhoid and polio vaccination.
    D'Costa DF, Cooper A, Pye IF.
    J R Soc Med; 1990 Oct 15; 83(10):653. PubMed ID: 2286971
    [No Abstract] [Full Text] [Related]

  • 28. Multiple sclerosis and vaccination.
    Miller H, Cendrowski W, Shapira K.
    Br Med J; 1967 Apr 22; 2(5546):210-3. PubMed ID: 6023105
    [No Abstract] [Full Text] [Related]

  • 29. Acute renal failure after TAB and cholera vaccination.
    Eisinger AJ, Smith JG.
    Br Med J; 1979 Feb 10; 1(6160):381-2. PubMed ID: 761023
    [No Abstract] [Full Text] [Related]

  • 30. [The potential epidemiological hazard of parenteral transmission of epidemic hepatitis as the result of vaccination].
    Moteiunas LI, Federene MP.
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Nov 10; 42(11):105-8. PubMed ID: 5875668
    [No Abstract] [Full Text] [Related]

  • 31. Cholera and typhoid vaccine. The current state of play.
    Cohen J.
    Aust Fam Physician; 1997 Aug 10; 26(8):943-6. PubMed ID: 9267060
    [Abstract] [Full Text] [Related]

  • 32. [Shock period evoked by typhus vaccine].
    Kotania W.
    Klin Oczna; 1968 Aug 10; 38(4):664-6. PubMed ID: 5702384
    [No Abstract] [Full Text] [Related]

  • 33. [Effect of some vaccine preparations on the course of experimental staphylococcal infection].
    Levina MN, Khomenko IM.
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Sep 10; 48():68-72. PubMed ID: 5113377
    [No Abstract] [Full Text] [Related]

  • 34. Subcutaneous versus intradermal typhoid vaccination by "jet-injector" apparatus.
    Dimache G, Croitoru M, Nicolae IN.
    Arch Roum Pathol Exp Microbiol; 1982 Sep 10; 41(3):259-64. PubMed ID: 7159215
    [No Abstract] [Full Text] [Related]

  • 35. [Antityphoid-paratyphoid vaccination. Current indications].
    Bastin R, Lagrange P.
    Rev Prat; 1972 Nov 25; 22(30):Suppl:71-3. PubMed ID: 4654960
    [No Abstract] [Full Text] [Related]

  • 36. Combined enteric and cholera vaccination by the intradermal route.
    Noble JE, Fielding P.
    J Hyg (Lond); 1965 Sep 25; 63(3):345-55. PubMed ID: 5212837
    [No Abstract] [Full Text] [Related]

  • 37. Immunogenicity and safety of Vi capsular polysaccharide typhoid vaccine in healthy persons in Korea.
    Lim SM, Jung HS, Kim MJ, Park DW, Kim WJ, Cheong HJ, Park SC, Lee KC, Shin YK, Tan HK, Kim SL, Sohn JW.
    J Microbiol Biotechnol; 2007 Apr 25; 17(4):611-5. PubMed ID: 18051272
    [Abstract] [Full Text] [Related]

  • 38. [Contraindications for typhoid vaccine therapy of inflammatory conditions of the eye].
    Drozdowska S.
    Klin Oczna; 1968 Apr 25; 38(4):801-3. PubMed ID: 5303958
    [No Abstract] [Full Text] [Related]

  • 39. Typhoid vaccine(s)--to give or not to give.
    Kalra A, Vashishtha VM.
    Indian Pediatr; 2009 Aug 25; 46(8):733-4; author reply 734-5. PubMed ID: 19717868
    [No Abstract] [Full Text] [Related]

  • 40. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO, Pasetti MF, Sztein MB, Livio S, Levine MM.
    J Infect Dis; 2004 Aug 01; 190(3):565-70. PubMed ID: 15243933
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.